These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16061928)

  • 1. Accuracy of a single fecal occult blood test in screening for colorectal cancer.
    Kane RC
    Ann Intern Med; 2005 Aug; 143(3):235. PubMed ID: 16061928
    [No Abstract]   [Full Text] [Related]  

  • 2. Office-based testing for fecal occult blood.
    Wolff ML
    Ann Intern Med; 2005 Aug; 143(3):235; author reply 236. PubMed ID: 16061927
    [No Abstract]   [Full Text] [Related]  

  • 3. Office-based testing for fecal occult blood.
    Hoffer EP
    Ann Intern Med; 2005 Aug; 143(3):235; author reply 236. PubMed ID: 16061926
    [No Abstract]   [Full Text] [Related]  

  • 4. Office-based testing for fecal occult blood.
    Jackson C; Craig R
    Ann Intern Med; 2005 Aug; 143(3):235-6; author reply 236. PubMed ID: 16061925
    [No Abstract]   [Full Text] [Related]  

  • 5. Office-based testing for fecal occult blood: do only in case of emergency.
    Sox HC
    Ann Intern Med; 2005 Jan; 142(2):146-8. PubMed ID: 15657163
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients.
    Friedman LC; Webb JA; Everett TE
    J Cancer Educ; 2004; 19(3):180-6. PubMed ID: 15458875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summaries for patients. What is the best way to test for colorectal cancer?
    Ann Intern Med; 2005 Jan; 142(2):I23. PubMed ID: 15657150
    [No Abstract]   [Full Text] [Related]  

  • 8. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.
    Collins JF; Lieberman DA; Durbin TE; Weiss DG;
    Ann Intern Med; 2005 Jan; 142(2):81-5. PubMed ID: 15657155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal occult blood testing in a noncompliant inner city minority population: increased compliance and adherence to screening procedures without loss of test sensitivity using stool obtained at the time of in-office rectal examination.
    Parikh A; Ramamoorthy R; Kim KH; Holland BK; Houghton J
    Am J Gastroenterol; 2001 Jun; 96(6):1908-13. PubMed ID: 11419847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancer screening with fecal occult blood testing].
    Díaz Tasende J; Marín Gabriel JC
    Rev Esp Enferm Dig; 2008 Jun; 100(6):315-9. PubMed ID: 18752358
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.